- Home
- Equipment
- asia middle east
- drug like molecules
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Drug Like Molecules Equipment Supplied In Asia Middle East
6 equipment items found
Manufactured by:Troikaa Pharmaceuticals Ltd. based inAhmedabad, INDIA
NASOMAX technology is a proprietary nasal drug delivery technology for safe and effective systemic delivery of the drug molecule, through the nasal route. Methylcobalamin has very low solubility in water. To provide optimum therapeutic benefit by the nasal route, Methylcobalamin is dissolved at 500 meg per 0.1 ml concentration, in a solvent system consisting of safe, non-irritating co-solvent ...
Manufactured by:Vilber based inMarne-la-Vallée cedex 3, FRANCE
The unrivaled NEWTON 7.0 is ideal for bioluminescence and fluorescence imaging of in vivo, ex vivo and in vitro ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
Manufactured by:Lumosa Therapeutics Co., Ltd. based inTaipei, TAIWAN
According to the WHO, stroke is the second leading cause of death with approximately 6 million deaths in the world per year. Stroke can be categorized as a hemorrhagic or an ischemic stroke. Studies show ischemic stroke, which LT3001 intends to treat, occurs in about 85% of all stroke cases. The only FDA approved treatment for ischemic strokes is tissue plasminogen activator (tPA, also known as ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC is committed to creating solutions for longstanding challenges in drug development by enabling new therapies with entirely unique properties. TLC has proprietary solution for pharmaceutical product development called LipAD®. LipAD® allows the design of medicines at the nanometer scale, improving drug solubility, protecting molecules from degradation, or targeting drug delivery to ...
Manufactured by:Shanghai Fosun Pharmaceutical (Group) Co. Ltd. based inShanghai City, CHINA
Messenger ribonucleic acid (mRNA) vaccines are a novel technology that stimulate the body’s own immune response. These vaccines contain information from messenger RNA, including the “blueprint” or code of a specific virus trait (virus antigen). The information enables the body to produce this antigen on its own: mRNA transfers the information for the production of the antigen to ...